Soulmates Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Antiverse secures £7m Series A led by Soulmates Ventures for AI-designed antibodies targeting undruggable diseases
Antiverse develops therapeutic antibodies designed using machine learning and built in its own laboratories. It generates and tests antibody candidates against difficult disease targets, including membrane proteins, for pharmaceutical and foundation partners.
Rightcharge secures £1.6m seed round led by Soulmates Ventures to simplify EV charging data for Europe's fleets
Rightcharge provides a payments platform for electric vehicle fleets that automates home charging reimbursements and consolidates public charging costs, linking directly to energy accounts to reduce admin, errors and charging expenses for businesses.
Signapse closes £2m seed round to accelerate accessibility for deaf people
Signapse builds generative AI software that translates written and spoken English into sign language, improving accessibility by enabling scalable, video-based communication for Deaf users across digital and physical environments.
More venture news
- 21 Apr 2026
Cerca MagneticsCerca Magnetics raises £3.8m Series A led by Guinness Ventures for wearable quantum brain scanner
Series AHealth - 15 Apr 2026
GizmoGizmo raises £16m Series A led by Shine Capital to help students study with interactive AI platform
Series AEducation - 15 Apr 2026
TraqCheckTraqCheck raises £6m Series A led by IvyCap Ventures for HR recruitment and screening software
Series AEnterprise
